LRRK2 modifies α-syn pathology and spread in mouse models and human neurons
Gregor Bieri, Michel Brahic, Luc Bousset, Julien Couthouis, Nicholas J. Kramer, Rosanna K. Ma, Lisa Nakayama, Marie Monbureau, Erwin B. Defensor, Birgitt Schüle, Mehrdad Shamloo, Ronald Melki, Aaron D. Gitler
This study shows that LRRK2 modifies α-syn aggregation and spread in both mouse and human models, suggesting potential therapeutic targets for Parkinson's disease.
Acta Neuropathologica · Mar 29, 2019Peer-reviewedNeuroscience